Read by QxMD icon Read

Intrauterine contraception

Torki Al-Otaibi, Osama A Gheith, Ayman M Nagib, Prasad Nair, Zakaria E Zakaria, Medhat A Halim, Tarek Said, Mohamed Abdelmonem, Yahya Makkeyah, Hassanen Aboatteya, Islam S Elsawi, Ahmed F Atta
OBJECTIVES: Pregnancy after kidney transplant has a high risk for maternal and fetal complications; however, it can be successful if patients are properly selected. Here, we studied outcomes and complications of pregnancies in kidney transplant recipients who received calcineurin inhibitor-based immunosuppression. MATERIALS AND METHODS: In this case control study, we reviewed patients who became pregnant between 2004 and 2017. For this analysis, each pregnancy was considered an event...
January 2019: Experimental and Clinical Transplantation
Shona L Ray-Griffith, Divyan Chopra, Zachary N Stowe, Bradley C Martin
OBJECTIVE: To describe claims for contraceptive services among reproductive aged women filling chronic opioid prescriptions. STUDY DESIGN: Using a large US commercial claims database, IMS Lifelink+, we identified women aged 15-44years who filled chronic opioid prescriptions (defined as a 90day supply of opioids without a 30day gap over a 180day time period) and had continuous pharmacy and medical enrollment for at least 90days prior to and 180days following their index opiod prescription...
February 11, 2019: Contraception
Anne Lethaby, Michelle R Wise, Maria Aj Weterings, Magdalena Bofill Rodriguez, Julie Brown
BACKGROUND: Menorrhagia or heavy menstrual bleeding (HMB) is an excessive blood loss that impairs a woman's quality of life, either physical, emotional, social or material. It is benign and not associated with pregnancy or any other gynaecological or systemic disease. Medical treatments used to reduce excessive menstrual blood loss (MBL) include prostaglandin synthetase inhibitors, antifibrinolytics, oral contraceptive pills, and other hormones. The combined oral contraceptive pill (COCP) is claimed to have a variety of beneficial effects, inducing a regular shedding of a thinner endometrium and inhibiting ovulation, thus having the effect of both treating HMB and providing contraception...
February 11, 2019: Cochrane Database of Systematic Reviews
Nicola Pluchino, Yveline Ansaldi, Andrea R Genazzani
Allopregnanolone (ALLO) has a crucial role in brain development and remodeling. Reproductive transitions associated with endocrine changes affect synthesis and activity of ALLO with behavioral/affective consequences. Pregnancy is characterized by an increased synthesis of progesterone/ALLO by the placenta, maternal and fetal brains. This suggests the critical role of these steroids in maternal brain adaptation during pregnancy and the development of the fetal brain. ALLO is brain protective during complications of pregnancy, such as preterm delivery or intrauterine growth restriction (IUGR), reducing the impact of hypoxia, and excitotoxic brain damage...
February 11, 2019: Hormone Molecular Biology and Clinical Investigation
Sofie Graner, Julia Mctaggart, Fanny Nordström, Emma Melander, Johan Widenberg, Helena Kopp Kallner
INTRODUCTION: The objective was to investigate the Pearl index for ectopic pregnancy in women using levonorgestrel intrauterine system (LNG-IUS) at time of conception. MATERIAL AND METHODS: This was a sub-study of a hospital based historical cohort including women with an ectopic pregnancy diagnosed in four referral hospitals in Stockholm Sweden between December 2013 and April 2017. Study participants and type of contraception at time of conception were identified through the electronic medical chart system...
February 8, 2019: Acta Obstetricia et Gynecologica Scandinavica
Jill Peterson, Aurélie Brunie, Salif Ndeye, Elisabeth Diatta, John Stanback, Dawn Chin-Quee
Background: Given the role that continued use of family planning (FP) by current users plays in increasing contraceptive prevalence rates (CPR), this research aims to measure method-specific continuation rates for fixed-site and community-based program interventions and to document reasons for discontinuation.  Methods: This research compared discontinuation rates for clients initiating family planning through two types of strategies-services provided at existing health centers that provided regular, ongoing services, and "one-off" outreach services in communities...
December 3, 2018: Gates open research
Alessandra Quintino-Moro, Denise Engelbrecht Zantut-Wittmann, Priscilla de Nazaré Silva Dos Santos, Vaneska Melhado-Kimura, Conceição Aparecida da Silva, Luis Bahamondes, Arlete Fernandes
PURPOSE: The aim of the study was to evaluate thyroid function profile as a possible factor influencing weight and body composition variation in new users of depot medroxyprogesterone acetate (DMPA). MATERIALS AND METHODS: A prospective, non-randomised, comparative study was conducted at the University of Campinas, Brazil. Women aged 18-40 years with a body mass index (BMI) less than 30 kg/m2 , normal oral glucose tolerance test, no known diseases, and using no medication, who opted to use DMPA were paired by age (±1 year) and BMI (±1 kg/m2 ) with women initiating copper intrauterine device (IUD) use...
February 5, 2019: European Journal of Contraception & Reproductive Health Care
Beth Sundstrom, Deborah Billings, Ellie Smith, Merissa Ferrara, Bill Albert, Katherine Suellentrop
INTRODUCTION: In South Carolina, 50% of all pregnancies are unintended. Intrauterine devices (IUDs) and the implant are recommended as top-tier contraceptive options for all women and adolescents. The Whoops Proof S.C. campaign was evaluated to determine if women (ages 18 to 29) who do not intend to become pregnant in the next year report greater awareness of and positive regard for IUDs and the implant after exposure to a multi-channel campaign. METHODS: A pair-matched group pretest-posttest quasi-experimental design was utilized...
February 1, 2019: Maternal and Child Health Journal
Mohamed Rezk, Elsayed Elshamy, Abd-Elhamid Shaheen, Mohamed Shawky, Hala Marawan
OBJECTIVE: To compare the effects of a levonorgestrel-releasing intrauterine system (LNG-IUS) and a copper intrauterine device (Cu-IUD) on menstrual changes and uterine artery Doppler indices. METHODS: A randomized clinical trial was conducted at Menoufia University Hospital, Egypt, between December 2016 and August 2017. 306 multiparous women desiring intrauterine contraception were randomly assigned to LNG-IUS (n=152) or Cu-IUD (n=154). Uterine artery pulsatility index (PI) and resistant index (RI) were measured before use, and 3 and 6 months after insertion, and associations with abnormal bleeding were evaluated...
February 1, 2019: International Journal of Gynaecology and Obstetrics
Hannat Akintomide
No abstract text is available yet for this article.
February 2019: British Journal of General Practice: the Journal of the Royal College of General Practitioners
Ziliang Wang, Chaohua Lou, Longmei Jin, Maohua Miao, Xiaowen Tu, Hong Liang, Yan Cheng, Wei Yuan
BACKGROUND: Unintended pregnancy and induced abortion among young (unmarried or nulliparous) women have become serious social and health issues in China, which are thought to partly result from low use of long-acting reversible contraception, such as intrauterine devices (IUDs). Considering that providers may play an especially important role in increasing use of this particular method, we investigated Chinese health care providers' attitudes and practices regarding IUDs use for nulliparous women, and further examine the potential factors and reasons contributing to their attitudes and practices...
January 31, 2019: Reproductive Health
Elina Pohjoranta, Maarit Mentula, Mika Gissler, Satu Suhonen, Oskari Heikinheimo
No abstract text is available yet for this article.
January 23, 2019: Human Reproduction
Ginnie Abarbanell, Naomi K Tepper, Sherry L Farr
OBJECTIVE: Women with congenital heart disease (CHD) are at increased risk of pregnancy complications and need information on safe, effective contraceptive methods to avoid unintended pregnancy. This systematic review examines evidence regarding safety of contraceptive use among women with CHD. METHODS: The PubMed database was searched for any peer-reviewed articles published through April 2018 that included safety outcomes associated with reversible contraceptive methods among women with CHD...
January 25, 2019: Congenital Heart Disease
Giuseppina Di Meglio, Colleen Crowther, Joanne Simms
Sexual and reproductive health is an important component of comprehensive health care for youth. This statement provides guidance for selecting and prescribing contraceptives for youth, including commonly prescribed hormonal contraceptives-the pill, patch, ring and injectable progestin-and long-acting reversible contraceptives (LARCs). LARCs, including subdermal implants (which are not available in Canada) and intrauterine contraceptives (IUCs), are substantially more effective during typical use than hormonal contraceptives...
July 2018: Paediatrics & Child Health
Xiaohui Huang, Rui Zhong, Liqin Zeng, Xuhui He, Qingshan Deng, Xiuhong Peng, Jieming Li, Xiping Luo
RATIONALE: It is extremely rare for an intrauterine contraception device (IUD) to cause uterine perforation and Sigmoid perforation for a long time without being detected. PATIENT CONCERNS: We present a case of a patient who has suffered from abdominal pain after 4 years of placement of an IUD, and found that the IUD was incarcerated by ultrasound. DIAGNOSES: Laparoscopic and hysteroscopic examination revealed that the incarcerated IUD caused uterine perforation and sigmoid perforation for a long time...
January 2019: Medicine (Baltimore)
Hannelore Rott
In Germany one-third of the women in fertile age use combined oral contraceptives (COCs), which consist mostly of ethinylestradiol (EE) and a synthetic progestin. Older COCs with norethisterone or levonorgestrel have a lower risk for venous thromboembolism (VTE) than newer COCs with desogestrel, drospirenone, or gestodene. This is also true for nonoral combined hormonal contraceptives. The risk of newer COCs containing estradiol instead of EE is not clear due to missing data. Progestin-only hormonal contraception is not associated with a significant increase of the risk for VTE with the exception of depot medroxyprogesterone acetate...
January 22, 2019: Hämostaseologie
Karin Emtell Iwarsson, Elin C Larsson, Kristina Gemzell-Danielsson, Birgitta Essén, Marie Klingberg-Allvin
INTRODUCTION: The objective of this study was to compare ever-in life contraception use, use of contraception at current conception, and planned use of contraception after an induced abortion, among three groups of women: migrants, second-generation migrants and non-migrant women, and to compare the types of contraception methods used and intended for future use among the three groups of women. METHODS: The cross-sectional study administered a questionnaire face-to-face to women aged 18 years and older who were seeking abortion care at one of six abortion clinics in Stockholm County from January to April 2015...
January 21, 2019: BMJ sexual & reproductive health
Jie Shen, Yan Che, Emily Showell, Ke Chen, Linan Cheng
BACKGROUND: Emergency contraception (EC) is using a drug or copper intrauterine device (Cu-IUD) to prevent pregnancy shortly after unprotected intercourse. Several interventions are available for EC. Information on the comparative effectiveness, safety and convenience of these methods is crucial for reproductive healthcare providers and the women they serve. This is an update of a review previously published in 2009 and 2012. OBJECTIVES: To determine which EC method following unprotected intercourse is the most effective, safe and convenient to prevent pregnancy...
January 20, 2019: Cochrane Database of Systematic Reviews
Kristen Upson, Helen B Chin, Erica E Marsh, Donna D Baird
BACKGROUND: Ovarian toxic exposures during early development may contribute to reduced ovarian reserve in adulthood. MATERIALS AND METHODS: We explored a range of intrauterine, infant, and childhood factors in relation to a biomarker of ovarian reserve, anti-Müllerian hormone (AMH) concentrations, in adulthood. We conducted a cross-sectional exploratory study of 1600 African American women 23-35 years of age residing in the Detroit, Michigan metropolitan area, who had serum AMH measurements (Ansh Labs PicoAMH enzyme-linked immunosorbent assay) and no previous polycystic ovarian syndrome diagnosis...
January 14, 2019: Journal of Women's Health
Marion Bachofner, Kerstin Blickenstorfer, Juliane Hutmacher, Lucia Wehrle, Brigitte Leeners, Gabriele Merki-Feld
OBJECTIVES: The aims of the study were to conduct an analysis of intrauterine device (IUD)-related outcomes, including continuation rates, reasons for discontinuation, rates of dislocation and risk factors for dislocation, in a clinical setting with regular ultrasound monitoring of the IUD position. METHODS: A retrospective chart review was carried out of all IUD insertions over a period of 5 years. RESULTS: A total of 755 IUDs were inserted over the study period...
January 10, 2019: European Journal of Contraception & Reproductive Health Care
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"